glp 1 by medvi is showing what a new kind of company can look like A telehealth platform selling GLP-1 weight-loss drugs directly to consumers Built in ~2 months with ~20K Now tracking toward $1.8B MEDVi - Personalized Telehealth Care

Availability of data and materials Coding and raw-data are available through Abbreviations GLP-1: Glucagon-like peptide-1 GIP: Glucose-dependent insulinotropic polypeptide TD2: Type 2 diabetes ELISA: Enzyme-linked immunosorbent assays BMI: Body mass index HbA1c: Glycated hemoglobin E%: Energy percent K 3 EDTA: Ethylene diamine tetraacetic acid HPLC: High performance liquid chromatography Min: Minimum value Max: Maximum value IQR: Interquartile range Conc.: Concentration EEG: Electroencephalogram PSG: Polysomnography References Wewer Albrechtsen NJ, Holst JJ, Cherrington AD, Finan B, Gluud LL, Dean ED, Campbell JE, Bloom SR, Tan TM, Knop FK, et al

found that GPX4 inhibitors make melanoma difficult to spread through blood vessels (Ubellacker et al., 2020)

Acta Pharmacol Sin 33:7581

Providing access to safe, affordable weight loss solutions is more critical than ever yet many Americans do not have consistent access to these life-changing treatments

GLP-1 multi agonists, PCSK9 targeted therapies, and SGLT2 inhibitors now influence multiple biologic systems simultaneously